Hollnberger J, Liu Y, Xu S, Chang S, et al. No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta. J Hepatol 2023 Apr 27:S0168-8278(23)00313-6. doi: 10.1016/j.jhep.2023.
PMID: 37120031